Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipelin...( SHENZHEN China Jan. 16 Asia-FirstC...),Health

SHENZHEN, China, Jan. 16 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches and its product pipeline for domestic and international markets in 2009.

In 2008 the Company released a total of ten products, achieving the goals for new product development outlined for the year, bringing the total number of products selling in the market to over 60. These products include four new products in patient monitoring and life support segment, the iPM 9800 patient monitor, the BeneHeart D6/D5 defibrillator, the EX55/65 compact anesthesia machines, and the AS3000 anesthesia delivery system. Mindray also released three new products in the medical imaging segment, including the DC-3 color ultrasound system, the DigiEye 560T and the DigiEye 561T digital radiography machines, and three new products in the in-vitro diagnostic segment, including the BC 5300/5380 hematology analyzer, the BS-380 biochemistry analyzer, and the BA88A semi-automatic biochemistry analyzer.

Additionally, in 2008 Mindray received US Food and Drug Administration ("FDA") 510(k) clearance for nine products, including the Beneview patient monitoring product series and the AS 3000 anesthesia delivery system, developed by Datascope Patient Monitoring ("DPM"), a Mindray company. To date, Mindray has received FDA 510(k) clearance for a total of 28 products, covering patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems.

To further expand its product portfolio, Mindray expects to launch seven to nine new products in 2009. Also, in 2009 the company will apply for FDA 510(k) clearance for four products. Upon approval, these products will help enhance Mind
'/>"/>